AGT and Shock: This is supported by a post-hoc of the "Angiotensin II for the Treatment of Vasodilatory Shock (ATHOS-3) trial” that found elevated renin levels in patients with catecholamine-resistant distributive shock9, and when Ang II was administered, serum renin levels decreased, which supports that the use of Ang II can suppress serum renin levels.